Skip to main content

ONCOLYTICS BIOTECH INC (ONCY) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2025)
-$28.8M
Total Assets (FY2025)
$7.6M
Total Equity (FY2025)
-$3.8M
Cash Flows from Operating Activities (FY2025)
-$20.1M

Source: ONCOLYTICS BIOTECH INC 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.

Discover Hub-Equity